Geneva Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-127,701
Closed -$10.3M 123
2020
Q2
$10.3M Sell
127,701
-3,047
-2% -$243K 0.22% 99
2020
Q1
$8.59M Buy
+130,748
New +$12.6M 0.24% 99

Other funds holding CRI

Geneva Capital Management's CRI Position: Q3 2020 in Review

Geneva Capital Management sold out of Carter's (CRI) in Q3 2020, closing a stake of 127,701 shares — an estimated $10.3M sold.

Geneva Capital Management first reported a position in CRI in Q1 2020 and held it in 2 quarters. The position peaked at $10.3M in Q2 2020. 284 funds tracked by Wall St. Rank hold CRI as of Q3 2020.

  • Geneva Capital Management reported no remaining Carter's position as of Q3 2020 after selling out during the quarter.
  • Geneva Capital Management sold 127,701 Carter's shares in Q3 2020, an estimated $10.3M.
  • Geneva Capital Management first reported a position in Carter's in Q1 2020 and held it in 2 quarters.
  • Geneva Capital Management's Carter's position peaked at $10.3M in Q2 2020.
  • 284 funds tracked by Wall St. Rank held Carter's as of Q3 2020.

Based on Geneva Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.